Missouri Judge Approves $7.25 Billion Bayer Roundup Settlement

A Missouri judge approved a landmark $7.25 billion settlement on Friday, resolving thousands of U.S. cancer claims against agrochemical maker Bayer over its Roundup weed killer.

Based on a settlement greenlit by a Missouri judge, pesticide producer Bayer will disburse up to $7.25 billion over a 20-year span to settle a multitude of lawsuits from American cancer patients who argued the company ought to have cautioned consumers that its widely used Roundup could cause lymphoma.

As covered by ABC News & Headlines – Australian Broadcasting Corporation, the nationwide agreement reached in Missouri pertains both to individuals currently suffering from Roundup-related illnesses and to those diagnosed with non-Hodgkin lymphoma in the years ahead. Claimants could receive an average ranging from $10,000 to $165,000, determined by their product usage history, their age at the time of diagnosis, and how severe their condition is.

St. Louis Circuit Judge Timothy Boyer said in a written judgment granting approval that the average individual payouts are “fair and adequate” and the total dollar amount is “among the largest in the history of mass tort personal-injury class action settlements,” according to AP News.

A closeup shot of a bottle of Roundup
Photo: ABC News & Headlines

The approved settlement includes $600 million for attorneys’ fees. Judge Boyer said that there was a risk Bayer would have filed for bankruptcy protection if the settlement had been rejected.

Legal Stakes and Settlement Terms

Bayer CEO Bill Anderson said in a statement that the court-approved settlement is “a decisive milestone in the company’s strategy to mitigate the risks of both pending and future Roundup litigation,” as noted by AP News.

The company inherited the legal problems surrounding Roundup when it bought Monsanto for $63 billion in 2018. Monsanto debuted Roundup weed killer in 1974 with the chemical glyphosate as its active ingredient, which was classified as “probably carcinogenic” by the International Agency for Research on Cancer, a unit of the World Health Organization, in 2015.

Judge Approves Bayer's $7.25 Billion Roundup Cancer Claims Settlement #Shorts — World Finance News Now

Christopher Seeger, a lawyer representing cancer patients, welcomed the decision, stating that “today’s final approval order delivers guaranteed compensation to Roundup cancer victims who have waited more than a decade for justice,” according to reporting from Dw.

Meanwhile, Bayer’s U.S. general counsel and global litigation leader Bill Dodero said that recent courtroom outcomes “should send a strong signal” that plaintiffs “will face significant challenges” pursuing future claims, as detailed by AP News. Prior to these proceedings, Bayer had already set aside $16 billion to cover legal costs related to Roundup cases, and its shares have fallen by 46% since the Monsanto takeover.

Two bottles of Roundup weedkiller
Photo: BBC

Payout Structure and Opposition

According to KOMU 8, the arrangement mandates that Bayer contribute yearly deposits to a dedicated fund across a period of up to 21 years, culminating in a maximum of $7.25 billion. In June, the U.S. Supreme Court determined that state courts cannot hear lawsuits against Bayer alleging a failure to warn about cancer risks, noting that federal rules do not mandate cancer warning labels and prohibit states from enforcing extra labeling obligations.

The legal filing was submitted within the St. Louis Circuit Court in Missouri, which functions as the base for Bayer’s North American crop science branch and the jurisdiction where numerous related legal actions have been filed.

Bayer, founded in 1863 as a dyestuffs factory in Germany, launched Aspirin in 1899, creating one of the world’s most recognized medicines. The company merged into IG Farben in 1925 and was reincorporated after World War II, later playing a central role in West Germany’s postwar economic recovery.

However, some attorneys have criticized the terms as restrictive. “This settlement is the scariest, worst future settlement that’s ever been contemplated,” attorney Gerson Smoger said during a September court hearing on whether the settlement was fair, according to WMUR. Despite objections from certain lawyers that individual payouts would be too low, the judge rejected those objections, emphasizing that further delays could leave seriously ill patients waiting years for compensation.

Worth a look


Discover more from Archyworldys

Subscribe to get the latest posts sent to your email.